Research and public health programs in epilepsy.
Healthcare issues related to the treatment of epilepsy.
Funding for epilepsy programs at CDC, HRSA, NIH
Reimbursement for healthcare services provided by epilepsy centers;
Issues related to anti-epileptic drugs.
Implementation of the Affordable Care Act
Duration: March 1, 2012
to
March 31, 2020
General Issues: Medical/Disease Research/Clinical Labs , Health Issues , Budget/Appropriations , Medicare/Medicaid , Pharmacy , Insurance
Spending: about $315,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2012: U.S. Senate, House of Representatives, Centers For Disease Control & Prevention (CDC), Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Centers For Medicare and Medicaid Services (CMS), Agency for Health Care Policy & Research, Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS),
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2020
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. terminated an engagement in which they represented National Association of Epilepsy Centers on April 16, 2020.
Original Filing: 301167813.xml
Lobbying Issues
Research and public health programs in epilepsy.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Healthcare issues related to the treatment of epilepsy.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for epilepsy programs at CDC, HRSA, NIH
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers;
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to anti-epileptic drugs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the Affordable Care Act
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on Jan. 16, 2020.
Original Filing: 301107907.xml
Lobbying Issues
Research and public health programs in epilepsy.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Healthcare issues related to the treatment of epilepsy.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for epilepsy programs at CDC, HRSA, NIH
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers;
Medicare Physician Fee Schedule and Hospital Outpatient PPS 2020 Proposed Rules
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to anti-epileptic drugs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the Affordable Care Act
Agencies Lobbied
U.S. Senate
3rd Quarter, 2019
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on Oct. 15, 2019.
Original Filing: 301065702.xml
Lobbying Issues
Research and public health programs in epilepsy.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Healthcare issues related to the treatment of epilepsy.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for epilepsy programs at CDC, HRSA, NIH
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers; modernizing PART D and Medicare Advantage Rule
Medicare Physician Fee Schedule and Hospital Outpatient PPS 2020 Proposed Rules
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to anti-epileptic drugs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the Affordable Care Act
Agencies Lobbied
U.S. Senate
2nd Quarter, 2019
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on July 15, 2019.
Original Filing: 301045781.xml
Lobbying Issues
Research and public health programs in epilepsy.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Healthcare issues related to the treatment of epilepsy.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for epilepsy programs at CDC, HRSA, NIH
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers; modernizing PART D and Medicare Advantage Rule
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to anti-epileptic drugs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the Affordable Care Act
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on April 11, 2019.
Original Filing: 301024297.xml
Lobbying Issues
Research and public health programs in epilepsy.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Healthcare issues related to the treatment of epilepsy.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for epilepsy programs at CDC, HRSA, NIH
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers; modernizing PART D and Medicare Advantage Rule
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to anti-epileptic drugs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the Affordable Care Act
Agencies Lobbied
U.S. Senate
4th Quarter, 2018
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on Jan. 22, 2019.
Original Filing: 301015557.xml
Lobbying Issues
Research and public health programs in epilepsy.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Healthcare issues related to the treatment of epilepsy.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for epilepsy programs at CDC, HRSA, NIH
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers; modernizing PART D and Medicare Advantage Rule
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to anti-epileptic drugs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the Affordable Care Act
Agencies Lobbied
U.S. Senate
3rd Quarter, 2018
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on Oct. 17, 2018.
Original Filing: 300987069.xml
Lobbying Issues
Research and public health programs in epilepsy.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Healthcare issues related to the treatment of epilepsy.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for epilepsy programs at CDC, HRSA, NIH
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to anti-epileptic drugs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the Affordable Care Act
Agencies Lobbied
U.S. Senate
2nd Quarter, 2018
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on July 19, 2018.
Original Filing: 300969228.xml
Lobbying Issues
Research and public health programs in epilepsy.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Healthcare issues related to the treatment of epilepsy.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for epilepsy programs at CDC, HRSA, NIH
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to anti-epileptic drugs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the Affordable Care Act
Agencies Lobbied
U.S. Senate
1st Quarter, 2018
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on April 20, 2018.
Original Filing: 300952612.xml
Lobbying Issues
Research and public health programs in epilepsy.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Healthcare issues related to the treatment of epilepsy.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for epilepsy programs at CDC, HRSA, NIH
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to anti-epileptic drugs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the Affordable Care Act
Agencies Lobbied
U.S. Senate
4th Quarter, 2017
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on Jan. 22, 2018.
Original Filing: 300934181.xml
Lobbying Issues
Research and public health programs in epilepsy.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Healthcare issues related to the treatment of epilepsy.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for epilepsy programs at CDC, HRSA, NIH
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to anti-epileptic drugs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the Affordable Care Act
Agencies Lobbied
U.S. Senate
3rd Quarter, 2017
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on Oct. 17, 2017.
Original Filing: 300905643.xml
Lobbying Issues
Research and public health programs in epilepsy.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Healthcare issues related to the treatment of epilepsy.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for epilepsy programs at CDC, HRSA, NIH
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to anti-epileptic drugs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the Affordable Care Act
Agencies Lobbied
U.S. Senate
2nd Quarter, 2017
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on July 17, 2017.
Original Filing: 300885781.xml
Lobbying Issues
Research and public health programs in epilepsy.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Healthcare issues related to the treatment of epilepsy.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for epilepsy programs at CDC, HRSA, NIH
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to anti-epileptic drugs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the Affordable Care Act
Agencies Lobbied
U.S. Senate
1st Quarter, 2017
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on April 18, 2017.
Original Filing: 300867937.xml
Lobbying Issues
Research and public health programs in epilepsy.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Healthcare issues related to the treatment of epilepsy.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for epilepsy programs at CDC, HRSA, NIH
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to anti-epileptic drugs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the Affordable Care Act
Agencies Lobbied
U.S. Senate
4th Quarter, 2016
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on Jan. 10, 2017.
Original Filing: 300844526.xml
Lobbying Issues
Research and public health programs in epilepsy.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Healthcare issues related to the treatment of epilepsy.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for epilepsy programs at CDC, HRSA, NIH
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to anti-epileptic drugs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the Affordable Care Act
Agencies Lobbied
U.S. Senate
3rd Quarter, 2016
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on Oct. 18, 2016.
Original Filing: 300830069.xml
Lobbying Issues
Research and public health programs in epilepsy.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Healthcare issues related to the treatment of epilepsy.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for epilepsy programs at CDC, HRSA, NIH
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to anti-epileptic drugs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the Affordable Care Act
Agencies Lobbied
U.S. Senate
2nd Quarter, 2016
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on July 18, 2016.
Original Filing: 300811600.xml
Lobbying Issues
Research and public health programs in epilepsy.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Healthcare issues related to the treatment of epilepsy.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for epilepsy programs at CDC, HRSA, NIH
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to anti-epileptic drugs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the Affordable Care Act
Agencies Lobbied
U.S. Senate
1st Quarter, 2016
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on April 12, 2016.
Original Filing: 300790072.xml
Lobbying Issues
Research and public health programs in epilepsy.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Healthcare issues related to the treatment of epilepsy.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for epilepsy programs at CDC, HRSA, NIH
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to anti-epileptic drugs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the Affordable Care Act
Agencies Lobbied
U.S. Senate
4th Quarter, 2015
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on Jan. 13, 2016.
Original Filing: 300771043.xml
Lobbying Issues
Research and public health programs in epilepsy.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Healthcare issues related to the treatment of epilepsy.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for epilepsy programs at CDC, HRSA, NIH
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to anti-epileptic drugs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the Affordable Care Act
Agencies Lobbied
U.S. Senate
3rd Quarter, 2015
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on Oct. 19, 2015.
Original Filing: 300757476.xml
Lobbying Issues
Research and public health programs in epilepsy.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Healthcare issues related to the treatment of epilepsy.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for epilepsy programs at CDC, HRSA, NIH
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to anti-epileptic drugs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the Affordable Care Act
Agencies Lobbied
U.S. Senate
2nd Quarter, 2015
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on July 15, 2015.
Original Filing: 300734814.xml
Lobbying Issues
Research and public health programs in epilepsy.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Healthcare issues related to the treatment of epilepsy.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for epilepsy programs at CDC, HRSA, NIH
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to anti-epileptic drugs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the Affordable Care Act
Agencies Lobbied
U.S. Senate
1st Quarter, 2015
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on April 16, 2015.
Original Filing: 300716636.xml
Lobbying Issues
Research and public health programs in epilepsy.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Healthcare issues related to the treatment of epilepsy.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for epilepsy programs at CDC, HRSA, NIH
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to anti-epileptic drugs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the Affordable Care Act
Agencies Lobbied
U.S. Senate
4th Quarter, 2014
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on Jan. 16, 2015.
Original Filing: 300697937.xml
Lobbying Issues
Research and public health programs in epilepsy.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Healthcare issues related to the treatment of epilepsy.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for epilepsy programs at CDC, HRSA, NIH
Agencies Lobbied
U.S. Senate
Lobbying Issues
reimbursement for healthcare services provided by epilepsy centers
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to anti-epileptic drugs
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the Affordable Care Act
Agencies Lobbied
U.S. Senate
3rd Quarter, 2014
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on Oct. 10, 2014.
Original Filing: 300675290.xml
Lobbying Issues
Research and public health programs in epilepsy.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Healthcare issues related to the treatment of epilepsy
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for epilepsy programs at CDC, HRSA, NIH.
Agencies Lobbied
U.S. Senate
Lobbying Issues
reimbursement for healthcare services provided by epilepsy centers
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to anti-epileptic drugs
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the Affordable Care Act
Agencies Lobbied
U.S. Senate
2nd Quarter, 2014
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on July 11, 2014.
Original Filing: 300655583.xml
Lobbying Issues
Research and public health programs in epilepsy.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Healthcare issues related to the treatment of epilepsy
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for epilepsy programs at CDC, HRSA, NIH.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to anti-epileptic drugs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the Affordable Care Act.
Agencies Lobbied
U.S. Senate
1st Quarter, 2014
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on April 11, 2014.
Original Filing: 300634622.xml
Lobbying Issues
Research and public health programs in epilepsy.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Healthcare issues related to the treatment of epilepsy.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for epilepsy programs at CDC, HRSA, NIH.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to anti-epileptic drugs.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Implementation of the Affordable Care Act.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2013
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on Jan. 14, 2014.
Original Filing: 300613604.xml
Lobbying Issues
Research and public health programs in epilepsy.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Healthcare issues related to the treatment of epilepsy.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for epilepsy programs at CDC, HRSA, NIH.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to anti-epileptic drugs.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Implementation of the Affordable Care Act.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2013
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on Oct. 15, 2013.
Original Filing: 300594103.xml
Lobbying Issues
Research and public health programs in epilepsy.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Healthcare issues related to the treatment of epilepsy.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for epilepsy programs at CDC, HRSA, NIH.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to anti-epileptic drugs.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Implementation of the Affordable Care Act.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2013
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on July 16, 2013.
Original Filing: 300573358.xml
Lobbying Issues
Research and public health programs in epilepsy.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Healthcare issues related to the treatment of epilepsy.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for epilepsy programs at CDC, HRSA, NIH.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to anti-epileptic drugs.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Implementation of the Affordable Care Act.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2013
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on April 18, 2013.
Original Filing: 300553905.xml
Lobbying Issues
Research and public health programs in epilepsy.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Healthcare issues related to the treatment of epilepsy.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for epilepsy programs at CDC, HRSA, NIH.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to anti-epileptic drugs.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Implementation of the Affordable Care Act.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2012
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on Jan. 15, 2013.
Original Filing: 300529317.xml
Lobbying Issues
Research and public health programs in epilepsy.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Healthcare issues related to the treatment of epilepsy.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for epilepsy programs at CDC, HRSA, NIH.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to anti-epileptic drugs.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2012
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on Oct. 17, 2012.
Original Filing: 300508584.xml
Lobbying Issues
Research and public health programs in epilepsy.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Healthcare issues related to the treatment of epilepsy.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for epilepsy programs at CDC, HRSA, NIH.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to anti-epileptic drugs.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2012
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for National Association of Epilepsy Centers , earning $5,000. The report was filed on July 16, 2012.
Original Filing: 300485407.xml
Lobbying Issues
Research and public health programs in epilepsy.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Healthcare issues related to the treatment of epilepsy.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for epilepsy programs at CDC, HRSA, NIH.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to anti-epileptic drugs.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2012
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. amended a lobbying report for representation of National Association of Epilepsy Centers in Q12012 on April 16, 2012.
Original Filing: 300461132.xml
Lobbying Issues
Research and public health programs in epilepsy.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Healthcare issues related to the treatment of epilepsy.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for epilepsy programs at CDC, HRSA, NIH.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to anti-epileptic drugs.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2012
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for National Association of Epilepsy Centers . The report was filed on April 16, 2012.
Original Filing: 300460951.xml
Lobbying Issues
Research and public health programs in epilepsy.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Healthcare issues related to the treatment of epilepsy.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for epilepsy programs at CDC, HRSA, NIH.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to anti-epileptic drugs.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2012
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. filed a lobbying registration on April 12, 2012 to represent National Association of Epilepsy Centers, effective March 1, 2012.
Original Filing: 300460019.xml
Issue(s) they said they’d lobby about: Funding for epilepsy programs at NIH, CDC, HRSA. Issues related to anti-epileptic drugs, reimbursement for epilepsy center services, public health policies related to epilepsy. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...